Genmab

Denmark

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
Epcoritamab, Phase 2 trial completes
Drugs
9
in active trials · 27 in all
Trials
35 active
67 since 2021

Drugs9

DrugHow it worksPartnerStageNext dateDetails
Bispecific CD20-directed CD3 T cell engager
Approved Mar 2027Phase 2 trial completes
PD-L1/4-1BB bispecific antibody
Phase 3 30 Jul 2027Phase 3 trial completes
—
Phase 3 Sep 2027Phase 3 trial completes
Monoclonal antibody
Phase 3 Jan 2028Phase 3 trial completes
—
Phase 1/2 Aug 2027Phase 1 trial completes
—
Phase 1 5 Apr 2029Phase 1 trial completes
—
Phase 1 Jun 2029Phase 1 trial completes
—
Phase 1 18 Oct 2029Phase 1 trial completes
—
Phase 1 Jan 2031Phase 1 trial completes

About

No active trial
18 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow Genmab

Following is part of Solo: you see every change to Genmab the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in